Titan Pharmaceuticals (TTNP)
(Delayed Data from NSDQ)
$3.93 USD
+0.01 (0.26%)
Updated Aug 6, 2025 02:59 PM ET
After-Market: $3.98 +0.05 (1.27%) 7:54 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Titan Pharmaceuticals, Inc. has a market cap of $3.58M, which represents its share price of $3.92 multiplied by its outstanding shares number of 0.91M. As a small-cap company, TTNP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TTNP 3.93 +0.01(0.26%)
Will TTNP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TTNP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TTNP
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Titan Pharmaceuticals Completes Securities Purchase Agreement
Titan Pharmaceuticals announces $600,000 private placement
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock | ...